Some drugmakers quietly concerned about legal risk with speedy FDA review program
Some drugmakers quietly concerned about legal risk with speedy FDA review program
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
BTC
ETH
USDT
XRP
USDC
SOL
TRX
FIGR_HELOC
DOGE
WBT
USDS
HYPE
LEO
ADA
JPMorgan beat earnings expectations amid record market revenue, but a downbeat outlook for net interest income hurt the stock.
Most popular articles this week
Latest news from global stock markets, tech giants, and financial sectors
Browse ArticlesBitcoin, Ethereum, altcoins, DeFi, NFTs, and blockchain technology
Browse ArticlesGold, silver, oil, natural gas, and other precious commodities
Browse Articles
Some drugmakers quietly concerned about legal risk with speedy FDA review program
Factbox-Global drugmakers rush to boost US presence as tariff threat looms
Factbox-Global companies that have sued the US government for tariff refunds
Exclusive-Drugmakers raise US prices on 350 medicines despite pressure from Trump
The Trump administration on Friday announced deals with nine drugmakers aimed at lowering pharmaceutical prices, bringing its total number of drug-pricing...
The White House is getting ready to announce more deals with drugmakers aimed at lowering drug prices.